A 16-amino-acid synthetic peptide (CAS 221231-10-3) corresponding to the C-terminal lipolytic region of human growth hormone (hGH 177-191) with an N-terminal tyrosine added for stability. Retains the fat-oxidation and fat-reduction activity of the parent hormone without its glucose-raising or IGF-1-stimulating effects. Developed by Metabolic Pharmaceuticals; failed Phase 2b for obesity. Holds TGA Australia "listable" status as a cosmetic/dietary supplement ingredient; not FDA-approved as a drug.
For research purposes only. Not medical advice.
Atomik Labz currently lists AOD-9604 at $7.02/mg, the lowest indexed price across 15 tracked research peptide vendors.
AOD-9604 ranges from $4.00/mg to $17.50/mg across 20 listings from 15 research peptide vendors, normalized to USD per milligram and refreshed daily.
15 research peptide vendors currently list AOD-9604 on PeptideScouter, with 12 in stock right now. We track 20 active listings across size and kit variants.
AOD-9604's CAS Registry Number is 221231-10-3. It is also sold as AOD, AOD-9064.